> top > projects > sonoma2 > docs > PubMed:30569443 > annotations
sonoma2  

PubMed:30569443 JSONTXT 2 Projects

Annnotations TAB TSV DIC JSON TextAE Lectin_function IAV-Glycan

Id Subject Object Predicate Lexical cue
T0 0-27 DISEASE denotes Familial hyperaldosteronism
T1 0-32 DISEASE denotes Familial hyperaldosteronism type
T2 9-36 DISEASE denotes hyperaldosteronism type III
T3 93-105 DISEASE denotes hypertension
T4 128-137 REG denotes secondary
T5 143-169 DISEASE denotes primary hyperaldosteronism
T6 151-169 DISEASE denotes hyperaldosteronism
T7 237-244 DISEASE denotes adenoma
T8 260-269 REG denotes remaining
T9 281-300 DISEASE denotes adrenal hyperplasia
T10 302-329 DISEASE denotes familial hyperaldosteronism
T11 339-361 MPA denotes aldosterone production
T12 365-389 DISEASE denotes adrenocortical carcinoma
T13 413-440 DISEASE denotes familial hyperaldosteronism
T14 442-444 DISEASE denotes FH
T15 450-452 DISEASE denotes FH
T16 477-479 DISEASE denotes FH
T17 480-483 DISEASE denotes III
T18 487-493 REG denotes caused
T19 494-496 REG denotes by
T20 506-515 VAR denotes mutations
T21 519-524 GENE denotes KCNJ5
T22 526-534 REG denotes encoding
T23 557-563 GENE denotes Kir3.4
T24 569-578 VAR denotes mutations
T25 579-584 REG denotes cause
T26 589-596 GENE denotes channel
T27 600-604 NEGREG denotes lose
T28 609-634 MPA denotes selectivity for potassium
T29 636-644 REG denotes allowing
T30 651-671 MPA denotes quantities of sodium
T31 675-680 MPA denotes enter
T32 685-689 CPA denotes cell
T33 713-733 CPA denotes membrane depolarizes
T34 735-770 CPA denotes voltage-gated calcium channels open
T35 772-795 CPA denotes calcium enters the cell
T36 797-807 REG denotes initiating
T37 825-830 REG denotes leads
T38 846-855 MPA denotes synthesis
T39 865-874 VAR denotes mutations
T40 878-883 GENE denotes KCNJ5
T41 898-907 REG denotes described
T42 933-941 DISEASE denotes adenomas
T43 952-960 REG denotes frequent
T44 977-979 DISEASE denotes FH
T45 999-1017 MPA denotes hyperaldosteronism
T46 999-1026 DISEASE denotes hyperaldosteronism symptoms
T47 1042-1068 CPA denotes to pharmacological therapy
T48 1075-1080 REG denotes leads
T49 1084-1107 CPA denotes bilateral adrenalectomy
T50 1169-1171 DISEASE denotes FH
T51 1176-1179 REG denotes due
T52 1180-1182 REG denotes to
T53 1199-1207 VAR denotes deletion
T54 1211-1216 GENE denotes KCNJ5
R0 T5 T4 ThemeOf primary hyperaldosteronism,secondary
R1 T5 T8 ThemeOf primary hyperaldosteronism,remaining
R10 T16 T17 ThemeOf FH,III
R11 T16 T18 ThemeOf FH,caused
R12 T16 T19 ThemeOf FH,by
R13 T17 T18 ThemeOf III,caused
R14 T17 T19 ThemeOf III,by
R15 T20 T16 CauseOf mutations,FH
R16 T20 T17 CauseOf mutations,III
R17 T20 T18 CauseOf mutations,caused
R18 T20 T19 CauseOf mutations,by
R19 T20 T22 CauseOf mutations,encoding
R2 T7 T4 ThemeOf adenoma,secondary
R20 T20 T25 CauseOf mutations,cause
R21 T20 T27 CauseOf mutations,lose
R22 T20 T29 CauseOf mutations,allowing
R23 T20 T33 CauseOf mutations,membrane depolarizes
R24 T20 T36 CauseOf mutations,initiating
R25 T20 T37 CauseOf mutations,leads
R26 T21 T20 ThemeOf KCNJ5,mutations
R27 T21 T24 ThemeOf KCNJ5,mutations
R28 T24 T18 CauseOf mutations,caused
R29 T24 T19 CauseOf mutations,by
R3 T7 T8 ThemeOf adenoma,remaining
R30 T24 T25 CauseOf mutations,cause
R31 T24 T27 CauseOf mutations,lose
R32 T24 T29 CauseOf mutations,allowing
R33 T24 T33 CauseOf mutations,membrane depolarizes
R34 T24 T36 CauseOf mutations,initiating
R35 T24 T37 CauseOf mutations,leads
R36 T26 T25 ThemeOf channel,cause
R37 T28 T27 ThemeOf selectivity for potassium,lose
R38 T30 T29 ThemeOf quantities of sodium,allowing
R39 T32 T31 ThemeOf cell,enter
R4 T10 T4 ThemeOf familial hyperaldosteronism,secondary
R40 T38 T37 ThemeOf synthesis,leads
R41 T39 T36 CauseOf mutations,initiating
R42 T39 T41 CauseOf mutations,described
R43 T40 T39 ThemeOf KCNJ5,mutations
R44 T42 T41 ThemeOf adenomas,described
R45 T42 T43 ThemeOf adenomas,frequent
R46 T44 T43 ThemeOf FH,frequent
R47 T44 T45 ThemeOf FH,hyperaldosteronism
R48 T44 T47 ThemeOf FH,to pharmacological therapy
R49 T44 T48 ThemeOf FH,leads
R5 T10 T8 ThemeOf familial hyperaldosteronism,remaining
R50 T45 T43 ThemeOf hyperaldosteronism,frequent
R51 T47 T43 ThemeOf to pharmacological therapy,frequent
R52 T49 T43 ThemeOf bilateral adrenalectomy,frequent
R53 T49 T48 ThemeOf bilateral adrenalectomy,leads
R54 T50 T51 ThemeOf FH,due
R55 T50 T52 ThemeOf FH,to
R56 T53 T50 CauseOf deletion,FH
R57 T53 T51 CauseOf deletion,due
R58 T53 T52 CauseOf deletion,to
R59 T54 T53 ThemeOf KCNJ5,deletion
R6 T11 T4 ThemeOf aldosterone production,secondary
R7 T11 T8 ThemeOf aldosterone production,remaining
R8 T12 T4 ThemeOf adrenocortical carcinoma,secondary
R9 T12 T8 ThemeOf adrenocortical carcinoma,remaining